Monsenso ASOCSE:MONSO +4.57%29 Net Margin % is -90.30% as of Dec. 2025. GuruFocus rates OCSE:MONSO with a GF Score™ of 29/100 and a GF Value™ of kr0.15 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Monsenso AS ranks worse than 90.06% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Monsenso AS's Net Income for the
six
months ended in Dec. 2025 was kr-3.38 Mil. Monsenso AS's Revenue for the
six
months ended in Dec. 2025 was kr3.74 Mil. Therefore, Monsenso AS's net margin for the quarter that ended in Dec. 2025 was -90.30%.
The historical rank and industry rank for Monsenso AS's Net Margin % or its related term are showing as below:
OCSE:MONSO'
s Net Margin % Range Over the Past 10 Years
Min: -126.41 Med: -53.75 Max: -2.56
Current: -81.03
OCSE:MONSO's Net Margin % is ranked worse than 90.06% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs OCSE:MONSO: -81.03
Monsenso AS (OCSE:MONSO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Monsenso AS Net Margin % Related Terms
Monsenso AS Net Margin % Historical Data
* Premium members only.
The historical data trend for Monsenso AS's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:MONSO vs VEEV, BTSG, TEM: Net Margin % Comparison
For the Health Information Services subindustry, Monsenso AS's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monsenso AS Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Monsenso AS's Net Margin % distribution charts can be found below:
* The bar in red indicates where Monsenso AS's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monsenso AS (OCSE:MONSO) has a Net Margin % of -90.30% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Monsenso AS and its competitors. According to the industry distribution chart, Monsenso AS ranks #598 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 90.1%.
Is Monsenso AS's Net Margin % too high?
Monsenso AS's current Net Margin % is -90.30%. Based on the distribution chart, Monsenso AS ranks #598 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Monsenso AS has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monsenso AS's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Monsenso AS ranks #598 out of 664 companies for Net Margin %. This places Monsenso AS in the lower half of its industry. The industry median Net Margin % is 2.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Monsenso AS and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monsenso AS's current Net Margin % is -90.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monsenso AS stock overvalued right now?
Based on GuruFocus' analysis, Monsenso AS (OCSE:MONSO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.15, compared to a current price of kr0.37 — trading 144% above its estimated fair value. The current Net Margin % is -90.30%. Monsenso AS's overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Monsenso AS (OCSE:MONSO), the current Net Margin % is -90.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monsenso AS (OCSE:MONSO) Overvalued in 2026?
Based on GuruFocus' analysis, Monsenso AS stock appears to be overvalued.
The current stock price of kr0.37 is trading 144% above its estimated GF Value™ of kr0.15.
GuruFocus considers Monsenso AS to be Significantly Overvalued.
Key valuation signals for OCSE:MONSO:
Net Margin %: -90.30%
GF Value™: kr0.15 vs. price of kr0.37 (144% above fair value)
No single metric tells the full story. See the OCSE:MONSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. The company's mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data, and the solution helps optimise the treatment and gives a detailed overview of an individual's health through the collection of outcome, adherence, and behavioral data.
29GF Score
Get the complete analysis for OCSE:MONSO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:MONSO has been successfully added to your 
